by adminAdrianRamirez | Nov 1, 2016 | Axim Biotechnologies, Press Releases
NEW YORK, NY –(Marketwired – November 01, 2016) – Medical Marijuana, Inc.(MJNA) today announced that its portfolio company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has begun pharmacokinetic/pharmacodynamics (PK/PD) studies with its CanChew...
by adminAdrianRamirez | Aug 4, 2016 | Axim Biotechnologies, Kannaway, Media Coverage, Press Releases
San Diego, CA – Aug. 4, 2016 – Medical Marijuana, Inc. (OTC: MJNA) announced today that the Company’s CEO Dr. Stuart Titus was interviewed by the Uptick Network’s Stock Day Radio Show about expanding access to cannabidiol (CBD)-based products to people across Latin...
by adminAdrianRamirez | May 17, 2016 | Axim Biotechnologies, Company News, Press Releases
MJNA’s Cannabis-Based Drug Development R&D Plans Expand With AXIM Biotech’s Clinical Trials On Patent-Pending AX-1602 Including Cannabigerol (CBG) SAN DIEGO, CA – May 17, 2016 — Medical Marijuana, Inc. (OTC: MJNA) is pleased to announce that its hemp biotech...
by adminAdrianRamirez | May 7, 2016 | Axim Biotechnologies, Cannabis Beauty Defined, Industry Updates, Kannactiv, Media Coverage
This year’s unofficial cannabis holiday brought in nearly $38 million in marijuana sales in the United States, as well as a series of press articles highlighting Medical Marijuana Inc.’s leading position in the country’s booming industry. Retail marijuana...
by adminAdrianRamirez | Apr 22, 2016 | Axim Biotechnologies, Cannabis Beauty Defined, Company News, Kannactiv, Kannaway, Media Coverage
A series of articles aimed at exploring the cannabis industry reveal the range of applications for cannabis and highlight Medical Marijuana Inc.’s influential position in this billion dollar market. It is not surprising that the internet would abound with articles...